Ligand Pharmaceuticals Is Buying Xoma for Nearly $740 Million
Corroborated by 4 sources from 4 publishers
TL;DR
Reports differ across sources; according to finance.yahoo.com, ligand Pharmaceuticals agreed to acquire Xoma Royalty Corporation for $39 per share in an all-cash deal valued at about $739 million, the two companies announced April 27.
Sources
1
Dow Jones Markets Main
https://www.wsj.com/health/pharma/ligand-pharmaceuticals-is-buying-xoma-for-nearly-740-million-5bb4a22f?mod=rss_markets_main
2
Yahoo Finance News
https://www.wsj.com/health/pharma/ligand-pharmaceuticals-is-buying-xoma-for-nearly-740-million-5bb4a22f?siteid=yhoof2&yptr=yahoo
3
Yahoo Finance News
https://finance.yahoo.com/sectors/healthcare/articles/ligand-pharmaceuticals-buying-xoma-royalty-131039926.html
4
Seeking Alpha Market News
https://seekingalpha.com/article/4894593-ligand-pharmaceuticals-incorporated-lgnd-m-and-a-call-transcript?source=feed_all_articles
5
Investing.com News
https://www.investing.com/news/analyst-ratings/bofa-raises-ligand-pharma-stock-price-target-on-xoma-acquisition-93CH-4639705
6
Seeking Alpha Market News
https://seekingalpha.com/article/4894732-ligand-pharmaceuticals-incorporated-lgnd-xoma-royalty-corporation-m-and-a-call-slideshow?source=feed_all_articles
7
Yahoo Finance News
https://finance.yahoo.com/sectors/healthcare/articles/ligand-pharmaceuticals-buy-xoma-royalty-231349961.html